Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
Torex Gold Reports First Copper Concentrate Production from Media Luna
06:00pm, Monday, 24'th Mar 2025
Processing plant tie-ins and restart complete; commercial production expected in coming weeks(All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - March 2
10x Genomics: Lower Cost Innovation May Drive A Rebound
03:12am, Thursday, 20'th Mar 2025
I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption, particu
Torex Gold Reports Year-End 2024 Reserves & Resources
06:00pm, Wednesday, 19'th Mar 2025
Drilling success continues to support reserve life extensions (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - Torex Gold Resources
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
04:05pm, Monday, 03'rd Mar 2025
10x Genomics' ATAC-Seq patents found valid and infringed PLEASANTON, Calif. , March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an u
Torex Gold Reports Excellent Drill Results from Media Luna West and Initial Results from Media Luna East
06:00am, Monday, 24'th Feb 2025
Compelling results return multiple high-grade intercepts at both Media Luna East and West (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - February 2
New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms PLEASANTON, Calif. , Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genom
Torex Gold Reports Q4 and Full Year 2024 Results
06:00pm, Wednesday, 19'th Feb 2025
2024 marks another solid year of operational and financial results; on track to return to positive free cash flow generation by mid-2025 (All amounts expressed in U.S. dollars unless otherwise stated)
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
04:05pm, Tuesday, 18'th Feb 2025
PLEASANTON, Calif. , Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties
03:10pm, Thursday, 13'th Feb 2025
On Wednesday, 10x Genomics Inc TXG reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of $(0.30).
10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript
08:53pm, Wednesday, 12'th Feb 2025
10x Genomics, Inc. (NASDAQ:TXG ) Q4 2024 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Cassie Corneau - Senior Director, IR and Strategic Finance Serge Saxonov - CEO and C
Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings
07:30pm, Wednesday, 12'th Feb 2025
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street e
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
06:46pm, Wednesday, 12'th Feb 2025
10x Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago.
10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
04:05pm, Wednesday, 12'th Feb 2025
PLEASANTON, Calif. , Feb. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year
Seeking Clues to 10x Genomics (TXG) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Tuesday, 11'th Feb 2025
Besides Wall Street's top -and-bottom-line estimates for 10x Genomics (TXG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during th
Cathie Wood dumped Palantir to buy these biotech stocks
08:42am, Thursday, 06'th Feb 2025
Ark Invest Management chief executive officer (CEO) Cathie Wood is a lauded yet controversial figure.
